2673-8449

Biologics

MDPI AG

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 12 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact12 DOIs
2

Deposit reference lists for 2 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 151 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A Current Review on the Role of Prebiotics in Colorectal Can… (10.3390/biologics3030012)
ORCID
31.38 17
2 Classification and Molecular Functions of Heparan Sulfate Pr… (10.3390/biologics4020008)
ORCID
28.65 13
3 Neoantigens: The Novel Precision Cancer Immunotherapy (10.3390/biologics3040017)
ORCID
26.98 11
4 Molecular Regulation and Therapeutic Applications of Brain-D… (10.3390/biologics5010007)
ORCID
23.86 8
5 Extracellular Vesicles: Tiny Messengers for Mighty RNA Deliv… (10.3390/biologics4010007)
ORCID
22.58 7
6 Monoclonal Antibody Development for Cancer Treatment Using t… (10.3390/biologics4010005)
ORCID
19.45 5
7 Short-Term Clinical Results of Single-Injection Autologous B… (10.3390/biologics4020015)
ORCID
17.47 4
8 Biologics in Pediatric Idiopathic Nephrotic Syndrome and Oth… (10.3390/biologics5010004)
ORCID
11.93 2
9 Novel Strategy for Alzheimer’s Disease Treatment through Ora… (10.3390/biologics3010003)
ORCID
7.53 1
10 Biologics—An Open Access Journal for Biological Drugs (10.3390/biologics1010001)
0.00 2
11 Overview of COVID-19 Disease: Virology, Epidemiology, Preven… (10.3390/biologics1010002)
0.00 26
12 The Peptide TAT-I24 with Antiviral Activity against DNA Viru… (10.3390/biologics1010003)
0.00 7
13 Can the European Hedgehog (Erinaceus europaeus) Be a Sentine… (10.3390/biologics1010004)
0.00 29
14 How to Train Your Phage: The Recent Efforts in Phage Trainin… (10.3390/biologics1020005)
0.00 35
15 Involvement of Probiotics and Postbiotics in the Immune Syst… (10.3390/biologics1020006)
0.00 179
16 Computational Chemistry to Repurposing Drugs for the Control… (10.3390/biologics1020007)
0.00 9
17 Induction of the CD24 Surface Antigen in Primary Undifferent… (10.3390/biologics1020008)
0.00 1
18 Optimization of a New Antihyperglycemic Formulation Using a… (10.3390/biologics1020009)
0.00 23
19 Isolation and Characterization of Bacteriophage ZCSE6 agains… (10.3390/biologics1020010)
0.00 32
20 A COVID-19 Overview and Potential Applications of Cell Thera… (10.3390/biologics1020011)
0.00 2
21 Biological Treatments in Inflammatory Bowel Disease: A Compl… (10.3390/biologics1020012)
0.00 17
22 Immunomodulatory Properties of Polyphenol-Rich Sugarcane Ext… (10.3390/biologics1020013)
0.00 6
23 Suitable Interpretation of Skin Prick Test and Biomedical Gu… (10.3390/biologics1020014)
0.00 0
24 Implications of Endothelial Cell-Mediated Dysfunctions in Va… (10.3390/biologics1020015)
0.00 22
25 Clinical Efficacy and Safety of Antiviral Drugs in the Exten… (10.3390/biologics1020016)
0.00 13
26 Is the Gut Microbiome a Target for Adjuvant Treatment of COV… (10.3390/biologics1030017)
0.00 4
27 Peptides in COVID-19 Clinical Trials—A Snapshot (10.3390/biologics1030018)
0.00 4
28 Pseudomonas aeruginosa Biofilm Formation and Its Control (10.3390/biologics1030019)
0.00 96
29 Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the… (10.3390/biologics1030020)
0.00 86
30 A Comprehensive Overview of the Newly Emerged COVID-19 Pande… (10.3390/biologics1030021)
0.00 11
31 Calcium Signaling Involves Na+/H+ Exchanger and IP3 Receptor… (10.3390/biologics1030022)
0.00 1
32 Immune Modulatory Effects of Probiotic Streptococcus thermop… (10.3390/biologics1030023)
0.00 22
33 In Silico Evaluation of Different Flavonoids from Medicinal… (10.3390/biologics1030024)
0.00 17
34 Identification and Effects of Skim Milk-Derived Bioactive An… (10.3390/biologics2010001)
0.00 3
35 Peptide Multimerization as Leads for Therapeutic Development (10.3390/biologics2010002)
0.00 13
36 In Silico Analysis of Honeybee Venom Protein Interaction wit… (10.3390/biologics2010003)
0.00 9
37 Acknowledgment to Reviewers of Biologics in 2021 (10.3390/biologics2010004)
References ORCID
0.00 0
38 The Promising Role of Mushrooms as a Therapeutic Adjuvant of… (10.3390/biologics2010005)
0.00 6
39 Toxicity Studies on Essential Oil from Phoenix dactylifera (… (10.3390/biologics2010006)
0.00 11
40 High Altitude Cerebral Edema: Improving Treatment Options (10.3390/biologics2010007)
0.00 21
41 Therapeutic Role of Antimicrobial Peptides in Diabetes Melli… (10.3390/biologics2010008)
0.00 13
42 The Coming of Age of Biosimilars: A Personal Perspective (10.3390/biologics2020009)
0.00 27
43 Abelmoschus esculentus (L.) Moench Pod Extract Revealed Anta… (10.3390/biologics2020010)
0.00 17
44 Antibacterial Activity of the Pyrogallol against Staphylococ… (10.3390/biologics2020011)
0.00 21
45 Antimicrobial Resistance (AMR) in Italy over the Past Five Y… (10.3390/biologics2020012)
0.00 11
46 Aged Population and Immunocompromised Patients: Impact on SA… (10.3390/biologics2030013)
0.00 5
47 Biosimilars: Harmonizing the Approval Guidelines (10.3390/biologics2030014)
0.00 25
48 Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients… (10.3390/biologics2030015)
0.00 9
49 Why Are We Still Talking about Ivermectin? Editorial Note on… (10.3390/biologics2030016)
0.00 0
50 Real-World Effectiveness and Safety of SDZ-ADL (Adalimumab B… (10.3390/biologics2040017)
0.00 0